Analyst consensus rating
Sionna Therapeutics Analyst Rating: none
Direct answer
Sionna Therapeutics's consensus rating is none.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $21.00.
Forecast evidence checked October 27, 2026.
Get free Sionna Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.87
- Average price target
- $21.00
- High price target
- $63.00
- Low price target
- $5.00
- Low target gap
- +29.2%
- Target upside
- +442.6%
- High target gap
- +1,527.9%
- Target range width
- 1,498.7%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Sionna Therapeutics?
Sionna Therapeutics has a verified none consensus. The same dataset has an average price target of $21.00.
How far are Sionna Therapeutics's low and high targets from the recorded price?
The low target implies +29.2%, while the high target implies +1,527.9%.
How many analysts are included in Sionna Therapeutics's consensus?
The verified consensus includes 7 analysts.
How is Sionna Therapeutics's target upside or downside calculated?
The average target of $21.00 is divided by the recorded price of $3.87, then one is subtracted to produce +442.6%. This does not guarantee a future return.
When was Sionna Therapeutics's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.